-
1 Comment
Eton Pharmaceuticals, Inc is currently in a long term downtrend where the price is trading 27.9% below its 200 day moving average.
From a valuation standpoint, the stock is 196.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 3965.0.
Eton Pharmaceuticals, Inc's total revenue sank by 82.4% to $81K since the same quarter in the previous year.
Its net income has dropped by 185.1% to $-8M since the same quarter in the previous year.
Finally, its free cash flow fell by 56.0% to $-7M since the same quarter in the previous year.
Based on the above factors, Eton Pharmaceuticals, Inc gets an overall score of 0/5.
None
Here's how to backtest a trading strategy or backtest a portfolio for ETON using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
